Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based studyResearch in context

Summary: Background: Much remains unknown surrounding the disease-modifying drugs (DMDs) used to treat multiple sclerosis and infection-related healthcare use in the ‘real-world’ setting. We examined if DMD exposure was associated with altered infection-related healthcare use. Methods: We assessed...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jonas Graf, Huah Shin Ng, Feng Zhu, Yinshan Zhao, José MA. Wijnands, Charity Evans, John D. Fisk, Ruth Ann Marrie, Helen Tremlett
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-01-01
coleção:	The Lancet Regional Health. Americas
Assuntos:	Multiple sclerosis Disease-modifying drugs Infections Healthcare use
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2667193X23002417
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!